Screening for cancer: Lessons learned from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial - Abstract

While the PLCO Cancer Screening trial demonstrated no observed mortality benefit associated with screening for prostate cancer with prostate-specific antigen and rectal exam, the knowledge gained about prostate cancer and screening and resources developed in completing the trial make the trial a success.

Written by:
Grubb RL, Pinsky P, Prorok PC, Andriole GL.   Are you the author?
Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.  

Reference: Eur Urol. 2015 May 7. pii: S0302-2838(15)00328-0.
doi: 10.1016/j.eururo.2015.04.026


PubMed Abstract
PMID: 25959167

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe